image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Our latest issue will be released in 10 days, don't miss out!

Playtech - EBITDA forecasts upgraded 10%

October 2014

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • PTEC
  • Price:
  • 699p
The shares soared after interims smashed expectations, leading to a 10% upgrade to EBITDA forecasts. Revenues, EBITDA and eps rose 21%, 28% and 45% to Eu214m, Eu97.6m and 33.3 cents respectively. Excluding acquisitions, EBITDA still impressively grew 19%. Net cash was Eu366m (30 June 2013: Eu 576m) following payment of a special dividend. Playtech makes its money from royalties based on a percentage of its licensees revenues and its flagship Casino product grew revenues 29% to Eu116.2m (54% revenues) driven by Ladbrokes, Gala Coral, Paddy Power and organic growth in Asia. Around 70% of Casino’s growth was attributable to core web casino, mainly slots and roulette, with mobile and live gaming, which streams real video of c ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X